| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/03/2010 | EP2148870A1 Pyrimidinone derivatives and methods of use thereof |
| 02/03/2010 | EP2148868A1 Novel aromatic heterocyclic carboxylic acid amide derivatives useful as potassium channel modulators |
| 02/03/2010 | EP2148867A1 Deuterated morpholinyl compounds |
| 02/03/2010 | EP2148866A2 Arylamide pyrimidone derivatives for the treatment of neurodegenerative diseases |
| 02/03/2010 | EP2148865A1 Pyrazole inhibitors of wnt signaling |
| 02/03/2010 | EP2148864A2 Fused-ring heterocycle opioids |
| 02/03/2010 | EP2148862A1 Dihydroquinone and dihydronaphthridine inhibitors of jnk |
| 02/03/2010 | EP2148861A1 Aryl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents |
| 02/03/2010 | EP2148858A1 Inhibitors of iap |
| 02/03/2010 | EP2148857A1 Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists |
| 02/03/2010 | EP2148727A2 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, methods for the preparation thereof, and uses thereof |
| 02/03/2010 | EP2148690A1 Compounds extracted from palm oil mill effluent for the treatment of cancer, compositions thereof and methods therewith |
| 02/03/2010 | EP2148688A1 Treatment of infections by carbon monoxide |
| 02/03/2010 | EP2148686A2 Novel active ingredient in cicatrization and use thereof |
| 02/03/2010 | EP2148685A2 Methods and compounds for vitamin d therapy |
| 02/03/2010 | EP2148684A2 Method of treating vitamin d insufficiency and deficiency |
| 02/03/2010 | EP2148681A2 Progesterone antagonist and selective progesterone modulator in the treatment of uterine bleeding |
| 02/03/2010 | EP2148679A1 Tetrahydropyrido[4,3-d]pyrimidinone derivatives and methods of use thereof |
| 02/03/2010 | EP2148678A1 Antiviral drugs for treatment or prevention of dengue infection |
| 02/03/2010 | EP2148677A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| 02/03/2010 | EP2148676A1 Use of sapacitabine to treat proliferative disease |
| 02/03/2010 | EP2148675A1 Anti-cancer medicine both for diagnosing and treating cancer |
| 02/03/2010 | EP2148672A1 Oxazolidinone for the treatment and prophylaxis of pulmonary hypertension |
| 02/03/2010 | EP2148671A1 Use of fungicides for treating fish mycoses |
| 02/03/2010 | EP2148670A1 Titration of tapentadol |
| 02/03/2010 | EP2148669A1 Tapentadol for treating pain from arthritis |
| 02/03/2010 | EP2148667A1 Use of cyclohexanehexol derivatives in the treatment of ocular diseases |
| 02/03/2010 | EP2148664A1 Use of antivirals in the treatment of medical disorders |
| 02/03/2010 | EP2148661A1 Oral controlled release compositions comprising vitamin d compound and waxy carrier |
| 02/03/2010 | EP2148660A2 Sustained release |
| 02/03/2010 | EP2148659A2 Low-dose doxepin formulations |
| 02/03/2010 | EP2148657A2 Process for obtaining steroidal phosphate compounds |
| 02/03/2010 | EP2148655A2 Pharmaceutical compositions of clopidogrel |
| 02/03/2010 | EP1917017B1 Treatment of amyotrophic lateral sclerosis with pyrimethamine and analogues |
| 02/03/2010 | EP1811988B1 Use of acetyl l-carnitine in combination with propionyl l-carnitine and sildenafil for the treatment of erectile dysfunction |
| 02/03/2010 | EP1778677B1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/03/2010 | EP1730147B1 Substituted 1,4,8-triazaspiro[4,5]decan-2-on compounds for use in the treatment of obesity |
| 02/03/2010 | EP1511742B1 Kinase inhibitors |
| 02/03/2010 | EP1421938B1 Antitumor agents and process for producing the same |
| 02/03/2010 | EP1351679B1 Method and composition for the treatment of diabetic neuropathy |
| 02/03/2010 | EP1078636B1 Pharmaceutical composition for use in emergency treatment and preparation method thereof |
| 02/03/2010 | CN201394205Y Device for coating Ankahuangmin capsule pellets |
| 02/03/2010 | CN101641103A Use of chitosans for the treatment of nail inflammatory diseases |
| 02/03/2010 | CN101641102A Pharmaceutical compositions comprising NK1 receptor antagonists and sodium channel blockers |
| 02/03/2010 | CN101641101A Methods of treating mood disorders |
| 02/03/2010 | CN101641100A Fluoroquinolones for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria |
| 02/03/2010 | CN101641099A Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1 |
| 02/03/2010 | CN101641098A Medicament for the treatment of endometriosis |
| 02/03/2010 | CN101641097A Treatment of melanoma |
| 02/03/2010 | CN101641096A Compositions and methods of using (R)-pramipexole |
| 02/03/2010 | CN101641095A Combination medicaments for treating bacterial infections |
| 02/03/2010 | CN101641094A Use of an inhibitor of tnfa plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis |
| 02/03/2010 | CN101641093A Imidazotriazines and imidazopyrimidines as kinase inhibitors |
| 02/03/2010 | CN101641092A Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated wit |
| 02/03/2010 | CN101641091A Tamibarotene capsule preparation |
| 02/03/2010 | CN101641090A Use of modafinil to treat restless leg syndrome |
| 02/03/2010 | CN101641089A An extract |
| 02/03/2010 | CN101641088A Treatment of gastrointestinal diseases |
| 02/03/2010 | CN101637624A Medical devices containing rapamycin analogs |
| 02/03/2010 | CN101637477A Drug composite containing troxerutin and ADP receptor antagonist |
| 02/03/2010 | CN101637476A Preparation for percutaneous administration and preparation method and application thereof |
| 02/03/2010 | CN101637475A Application of paederoside acid or plant extract containing same |
| 02/03/2010 | CN101637474A New application of asperosaponin VI |
| 02/03/2010 | CN101637473A Drug combination containing raloxifene and application thereof |
| 02/03/2010 | CN101637472A Novel ceftriaxone compound antibiotic and clinic use thereof |
| 02/03/2010 | CN101637471A Application of 3-fluorin-5-(trifluoromethyl)-N-(2-(1-piperidyl) ethyl) benzamide hydrochloride in the preparation of medicine and feed for resisting H5N1 type avian influenza virus |
| 02/03/2010 | CN101637470A Pharmaceutical composition for preventing and curing acnes and application thereof |
| 02/03/2010 | CN101637469A Combination of tablets, capsules and granules of sodium glycididazole of anticancer sensitizers and preparation method of tablets, capsules and granules of sodium glycididazole |
| 02/03/2010 | CN101637468A Application of isodexyelephantopin in the preparation of anti-angiogenic rebirth medicine |
| 02/03/2010 | CN101637467A Herba epimedii aglycone or cyclo-herba epimedii aglycone phospholipid compound and preparation method thereof |
| 02/03/2010 | CN101637466A Application of icaritin in preparing medicament for preventing and treating cardiovascular and cerebrovascular diseases |
| 02/03/2010 | CN101637465A Medical application of 1-methyl-2-amino terephthalate |
| 02/03/2010 | CN101637464A Drug composite containing calcium 2,5-dihydroxysulfonate and ADP receptor antagonist |
| 02/03/2010 | CN101637462A Compositions for conjugated estrogens and associated methods |
| 02/03/2010 | CN100586948C Crystalline anticholinergic, method for its preparation, and use thereof in medicament preparation |
| 02/03/2010 | CN100586945C Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 02/03/2010 | CN100586481C Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 02/03/2010 | CN100586441C Compound sulfamonomethoxine sodium injection and preparation method thereof |
| 02/03/2010 | CN100586440C Aspartic vitamin eye drops and preparation method thereof |
| 02/03/2010 | CN100586439C Jixuedai dispersion tablet having function of promoting wound reunion, and its preparation method |
| 02/03/2010 | CN100586438C Jixuedai drip pill with action of promoting wound reunion, and its preparation method |
| 02/03/2010 | CN100586437C Slow released aminoglycoside antituberculotic preparation |
| 02/03/2010 | CN100586436C Lotepredenol etabonate gernebcin suspension solution and method for preparing the same |
| 02/03/2010 | CN100586435C Carmofur sustained-release implantation agent for curing entity tumour |
| 02/03/2010 | CN100586434C Anti-itching agent |
| 02/03/2010 | CN100586433C Use of protoberberine alkaloid in preparing against bacterial resistance medicament |
| 02/03/2010 | CN100586432C Yiganling dispersion tablet for treating liver disease and its preparation method |
| 02/03/2010 | CN100586431C Application of procyanidin B2 in preparing medicine for preventing and treating diabetes and vascular complication |
| 02/03/2010 | CN100586430C Paclitaxel/multialkene paclitaxel liposome composite medicine and preparation method thereof |
| 02/03/2010 | CN100586429C Antidepressant |
| 02/03/2010 | CN100586428C Compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection and application thereof in preparing medicine |
| 02/03/2010 | CN100586297C Composition against periodontal bacteria |
| 02/02/2010 | US7655810 Bis(1,2-bis(2,5-dimethylphosphorano)ethane)gold (I) chloride; has optical activity; low side effects; production of the phosphine transition metal complex is industrially advantageous |
| 02/02/2010 | US7655808 Leptomycin B; antiproliferative agents; antitumor agents; antcarcinogenic agents; inhibiting the export of a protein from the nucleus of a cell via a CRM1-mediated process; tissue-targeted therapy; cancer of human breast, lung, ovaries, prostate, and bladder, and leukemia cell |
| 02/02/2010 | US7655804 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 02/02/2010 | US7655802 Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs |
| 02/02/2010 | US7655801 Substituted carbamic acid quinolin-6-yl esters useful as acetylcholinesterase inhibitors |
| 02/02/2010 | US7655800 Crystalline 1H-imidazo[4,5-b]pyridin-5-amine, 7-[5-[(cyclohexylmethylamino)-methyl]-1H-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its pharmaceutical uses |
| 02/02/2010 | US7655799 oxidation of 2-{[2-(Diisopropylamino)ethyl]thio}ethyl N,N,N',N'-tetrakis(2-chloroethyl)phosphorodiamidate to 2-{[2-(diisopropylamino)ethyl]sulfonyl}ethyl N,N,N',N'-tetrakis(2-chloroethyl)phosphorodiamidate; salt formation, anticarcinogenic agent |
| 02/02/2010 | US7655797 Intermediates for making 2,4-pyrimidinediamine compounds |